Drug Shortage Report for PROCAINAMIDE HYDROCHLORIDE INJECTION USP

Last updated on 2021-03-29 History
Report ID 135226
Drug Identification Number 02184486
Brand name PROCAINAMIDE HYDROCHLORIDE INJ. USP
Common or Proper name PROCAINAMIDE HYDROCHLORIDE INJ. USP
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) PROCAINAMIDE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 ML 10 LIVI CA
ATC code C01BA
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-03-05
Estimated end date 2021-03-26
Actual end date 2021-03-26
Shortage status Resolved
Updated date 2021-03-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-03-29 French Compare
v5 2021-03-29 English Compare
v4 2021-03-15 French Compare
v3 2021-03-15 English Compare
v2 2021-03-08 French Compare
v1 2021-03-08 English Compare

Showing 1 to 6 of 6